Infinium Pharmachem IPO vs Maiden Forgings IPO

Comparision between Infinium Pharmachem IPO and Maiden Forgings IPO.

IPO Details

Infinium Pharmachem IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Maiden Forgings IPO is a SME Book Built Issue proposed to list at BSE SME.

	Infinium Pharmachem IPO	Maiden Forgings IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Book Built Issue
Listing At	NSE SME	BSE SME
Lead Managers	Swastika Investmart Ltd	Share India Capital Services Private Limited
Registrar	Bigshare Services Pvt Ltd	Maashitla Securities Private Limited
Market Maker	Swastika Investmart Limited	Share India Securities Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Infinium Pharmachem IPO is up to ₹25.26 Cr whereas the issue size of the Maiden Forgings IPO is up to ₹23.84 Cr. The final issue price of Infinium Pharmachem IPO is ₹135.00 per share and of Maiden Forgings IPO is ₹63.00 per share.

	Infinium Pharmachem IPO	Maiden Forgings IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)		₹60.00 per share
Issue Price (Upper)		₹63.00 per share
Issue Price (Final)	₹135.00 per share	₹63.00 per share
Discount (Retail)
Discount (Employee)	₹13.50 per share
Market Lot Size	1000 shares	2000 shares
Fresh Issue Size	18,75,000 shares	37,84,000 shares
Fresh Issue Size (Amount)	up to ₹25.26 Cr	up to ₹23.84 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	18,75,000 shares	37,84,000 shares
Issue Size Total (Amount)	up to ₹25.26 Cr	up to ₹23.84 Cr

IPO Timetable

Infinium Pharmachem IPO opens on Mar 31, 2023, while Maiden Forgings IPO opens on Mar 23, 2023. The closing date of Infinium Pharmachem IPO and Maiden Forgings IPO is Apr 05, 2023, and Mar 27, 2023, respectively.

	Infinium Pharmachem IPO	Maiden Forgings IPO
Anchor Bid Date		Mar 22, 2023
Issue Open	Mar 31, 2023	Mar 23, 2023
Issue Close	Apr 05, 2023	Mar 27, 2023
Basis Of Allotment (Tentative)	Apr 11, 2023	Mar 31, 2023
Initiation of Refunds (Tentative)	Apr 12, 2023	Apr 03, 2023
Credit of Share (Tentative)	Apr 13, 2023	Apr 05, 2023
Listing date (Tentative)	Apr 17, 2023	Apr 06, 2023
Anchor Lockin End date 1	May 11, 2023	Apr 30, 2023
Anchor Lockin End date 2	Jul 10, 2023	Jun 29, 2023

Financials

Infinium Pharmachem IPO P/E ratio is 7.83, as compared to Maiden Forgings IPO P/E ratio of 8.38.

Infinium Pharmachem IPO

Maiden Forgings IPO

Financial

Infinium Pharmachem Private Limited Financial Information (Restated Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Total Borrowing
31-Mar-20	2,244.60	3,941.64	93.40	424.74	566.17
31-Mar-21	3,418.27	7,115.37	272.48	702.32	579.47
31-Mar-22	5,899.95	10,005.25	610.64	1,310.22	1,385.01
30-Sep-22	7,075.71	7,985.39	551.01	1,855.77	1,614.71
Amount in ₹ Lakhs

Maiden Forgings Limited Financial Information (Restated Standalone)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	9,890.05	20,440.37	165.95	2,136.92	1,672.02	5,788.13
31-Mar-21	10,484.25	19,937.49	168.94	2,899.11	2,377.71	5,428.93
31-Mar-22	11,014.23	21,083.72	213.94	3,113.05	2,591.65	6,170.75
31-Dec-22	12,595.69	16,381.04	801.51	3,914.56	2,871.76	6,525.17
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

100%

Promoter Shareholding (Post-Issue)

73.05%

73.37%

P/E Ratio

7.83

8.38

Market Cap

₹93.93 Cr.

₹89.54 Cr.

ROE

ROCE

Debt/Equity

EPS

RoNW

Shares Offered

In the Infinium Pharmachem IPO retail investors (RII) are offered 9,37,500 shares while in Maiden Forgings IPO retail investors are offered 9,37,500 shares. Qualified institutional buyers (QIB) are offered 0 shares in Infinium Pharmachem IPO and 3,60,000 shares in Maiden Forgings IPO.

	Infinium Pharmachem IPO	Maiden Forgings IPO
Anchor Investor Reserveration
Market Maker Reserveration	94,000 shares	1,90,000 shares
QIB	0 shares	3,60,000 shares
NII	9,37,500 shares	9,70,000 shares
RII	9,37,500 shares	22,64,000 shares
Employee	0 shares	0 shares
Others
Total	18,75,000 shares	37,84,000 shares

Bids Received (Subscription)

Infinium Pharmachem IPO subscribed 1.84x in total, whereas Maiden Forgings IPO subscribed 1.20x.

	Infinium Pharmachem IPO	Maiden Forgings IPO
QIB (times)		1.00x
NII (times)	1.80x	1.42x
Big NII (times)
Small NII (times)
RII (times)	1.86x	1.12x
Employee (times)
Other (times)
Total (times)	1.84x	1.20x

Compare with others

Infinium Pharmachem IPO	Maiden Forgings IPO
Pattech Fitwell Tube Components IPO	Sancode Technologies IPO
Sancode Technologies IPO	Exhicon Events IPO
Exhicon Events IPO	Sotac Pharmaceuticals IPO
Sotac Pharmaceuticals IPO	MOS Utility IPO
MOS Utility IPO	Infinium Pharmachem IPO
Maiden Forgings IPO	Command Polymers IPO
Command Polymers IPO	Dev Labtech Venture IPO
Dev Labtech Venture IPO	Nirman Agri Genetics IPO
Nirman Agri Genetics IPO	Labelkraft Technologies IPO
Labelkraft Technologies IPO	VELS Film International IPO

Comments

Add a public comment...